101 related articles for article (PubMed ID: 32633372)
1. MED27 promotes malignant behavior of cells by affecting Sp1 in breast cancer.
Wang YH; Huang JH; Tu JF; Wu MH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6802-6808. PubMed ID: 32633372
[TBL] [Abstract][Full Text] [Related]
2. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
3. Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/β-catenin signaling pathway and the epithelial-mesenchymal transition process.
He H; Dai J; Yang X; Wang X; Sun F; Zhu Y
Biol Chem; 2018 May; 399(6):593-602. PubMed ID: 29730647
[TBL] [Abstract][Full Text] [Related]
4. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
[TBL] [Abstract][Full Text] [Related]
5. MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4.
Wang R; Yu W; Zhu T; Lin F; Hua C; Ru L; Guo P; Wan X; Xue G; Guo Z; Han S; Lv K; Zhang G; Ge H; Guo W; Xu L; Deng W
Cancer Sci; 2023 Jun; 114(6):2277-2292. PubMed ID: 36786527
[TBL] [Abstract][Full Text] [Related]
6. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Guo L; Fang L; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of mediator complex subunit 27 suppresses gastric cancer cell metastasis and angiogenesis via Wnt/β-catenin pathway.
Han X; Liu H; Tang X; Zhao Y
Tissue Cell; 2022 Dec; 79():101973. PubMed ID: 36371844
[TBL] [Abstract][Full Text] [Related]
8. LINC00483 is regulated by IGF2BP1 and participates in the progression of breast cancer.
Qiao YS; Zhou JH; Jin BH; Wu YQ; Zhao B
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1379-1386. PubMed ID: 33629308
[TBL] [Abstract][Full Text] [Related]
9. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
10. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-18a inhibits cell growth and induces apoptosis in osteosarcoma by targeting MED27.
Ding J; Sha L; Shen P; Huang M; Cai Q; Li J
Int J Oncol; 2018 Jul; 53(1):329-338. PubMed ID: 29693135
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LINC01287 promotes breast cancer cells proliferation and metastasis by activating Wnt/ß-catenin signaling.
Song C; Sun P; He Q; Liu LL; Cui J; Sun LM
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4234-4242. PubMed ID: 31173295
[TBL] [Abstract][Full Text] [Related]
14. MiR-539 inhibits the malignant behavior of breast cancer cells by targeting SP1.
Cai F; Chen L; Sun Y; He C; Fu D; Tang J
Biochem Cell Biol; 2020 Jun; 98(3):426-433. PubMed ID: 31742423
[TBL] [Abstract][Full Text] [Related]
15. JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3.
Li L; Gao P; Li Y; Shen Y; Xie J; Sun D; Xue A; Zhao Z; Xu Z; Zhang M; Li B; Jiang J
Breast Cancer Res Treat; 2014 Oct; 147(3):487-500. PubMed ID: 25193278
[TBL] [Abstract][Full Text] [Related]
16. Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2008 Feb; 283(9):5335-43. PubMed ID: 18165235
[TBL] [Abstract][Full Text] [Related]
17. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
18. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract][Full Text] [Related]
19. MiR-940 promotes malignant progression of breast cancer by regulating FOXO3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract][Full Text] [Related]
20. Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression.
Zhang X; Fan Y; Liu B; Qi X; Guo Z; Li L
Breast Cancer; 2017 May; 24(3):433-441. PubMed ID: 27572702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]